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Two monoclonal antibodies (MAb 1 and IV) have been prepared which showed high and specific reactions 
towards bovine heart mitochondrial coupling factor B (FB). Both have been identified as sub-type IgG, of 
mouse immunoglobulins. MAb I reacts with purified and functionally active Fs, alkylated or oxidized forms 
of FB and even with peptides formed on digestion of Fe with trypsin. When used together, MAb I and IV 
reacted with FB in immunoblots of normal and urea treated samples of mitochondria, submitochondrial 
particles, ammonia-EDTA extracted particles, and H+-ATPase. Both MAbs inhibited Fs-stimulated ATP- 
dependent reverse electron flow activity when Fe was incubated with the antibody either before or after 
its addition to F,-deficient AE-particles. Reactivity of MAb I towards Fgdeclined upon exposure of F, 
to guanidine HCI while reactivity of MAb IV remained unaltered. 
Coupling factor B H+-ATPase 
1. INTRODUCTION 
The mitochondrial H+-ATPase consists of two 
parts, the hydrophobic membrane sector (Fo) and 
the more hydrophilic F1, bearing the catalytic sites 
for ATP hydrolysis and synthesis. There is a close 
similarity between the F1 subunits from different 
sources with respect o the number, size and func- 
tion [l]. Unlike F1, FO from different sources ap- 
pears to be more variable in the number of 
subunits. While the bacterial Fo is known to con- 
tain 3 subunits [2], the composition of eukaryotic 
Fo remains unelucidated. 
Antibodies to F1 have proved to be useful for 
studying the role of F1 subunits in the membrane. 
Authors in [3], using rabbit antiserum to F1, found 
that F1 complexes faced the matrix side of the 
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Mitochondria Monoclonal antibody 
mitochondrial inner membranes. Anti-F1 serum 
has been successfully used to precipitate 
oligomycin sensitive ATPase from Triton X-100 
solubilized submitochondrial particles [l]. The 
disposition of different subunits of F1 has been 
studied by radioactive labeling of submitochon- 
drial particles and mitochondria followed by im- 
munoprecipitation of oligomycin-sensitive ATPase 
VI. 
The elegant study in [4] using monospecific rab- 
bit antisera to each of the different F1 subunits 
showed that the fl and y subunits are required for 
ATP hydrolysis, whereas the 6 and 6 subunits are 
involved in the binding of F1 to the membrane. By 
following a similar approach, it has been 
demonstrated [5] that the P-subunit, and small 
portions of (Y and y are required for the hydrolytic 
activity of Fl-ATPase. All the observations made 
so far using polyclonal antisera have offered a 
general understanding of the behavior of in- 
dividual subunits. More precise information re- 
garding the structural domains of the subunits that 
are involved in either the catalysis or binding to a 
different subunit or membrane could be obtained 
by using monoclonal antibodies. The recent exam- 
ple is the determination of subunit stoichiometry 
Published by Elsevier Science Publishers B. V. 
00145793/85/$3.30 0 1985 Federation of European Biochemical Societies 143 
Volume 179, number 1 FEBS LETTERS January 1985 
of a and ,8 subunits in the pig heart mitochondrial from such wells were screened for antibodies to Fn 
ATPase [6], where monoclonal antibodies have by ELISA. Wells that contained antibodies to Fg 
been used to illustrate the presence of more than were cloned by the method of limiting dilution. 
two copies of CY and ,8 subunits per H+-ATPase Antibody containing ascitic fluid was generated by 
complex. There is a need for similar studies to be injecting pristane-primed BALB/c mice with l-2 
carried out on the Fo components. x lo6 hybridoma cells per mouse. 
The role of Fe in beef heart mitochondrial 
H+-ATPase has been clearly established [7-g]. It is 
an essential component of Fc,, required for ATP 
synthesis but not for hydrolysis. To aid further 
studies on the mechanism of Fn action, we have 
obtained two lines of potent monoclonal Fn an- 
tibodies, some of the properties of which are 
presented here. 
For immunoglobulin subtype identification Fn- 
MAb complex on ELISA plate was treated with 
type specific rabbit antisera, i.e., specific to cy, y, 
yza, Y2b, 73, p heavy chains and x and h light chains 
of mouse immunoglobulins. Further reaction was 
carried out as for the regular ELISA technique, us- 
ing peroxidase conjugated goat antiserum to rabbit 
immunoglobulins. 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
The myeloma NS-1 cell lines were supplied by Dr 
Timothy Springer, Harvard Medical School. 
BALB/c mice were purchased from Charles River 
Breeding Station. Peroxidase conjugate of goat an- 
timouse immunoglobulin was obtained from Cap- 
pell Laboratories. Mouse immunoglobulin sub- 
type identification kit was obtained from 
Boehringer-Mannheim. All other chemicals were 
of reagent grade. 
Isolation of beef heart mitochondria [lo], ETPn 
[l 11, Fo [12], preparation of AE-particles [lo], 
purification of Fn [lo], assay of ATP-driven 
NAD+ reduction by succinate [lo], ELISA [13], 
and electrophoretic transfer of proteins to 
nitrocellulose paper and immunostaining [ 141 were 
carried out as described previously. 
Twenty antibody producing colonies were iden- 
tified by ELISA and the best 4 were cloned. The 
ascitic fluids of MAb I and MAb IV were found to 
be most potent. The lower limit of sensitivity by 
ELISA was seen at 1: 2000000 and 1: 250000 dilu- 
tions of MAb I and IV, respectively (fig.1). The 
binding of the two antibodies was additive when 
used in subsaturating amounts. The titers with 
MAb II and III were low. Both MAb I and IV 
reacted strongly with a polypeptide corresponding 
in mobility to Fn in immunoblots whereas the 
MAb II and III reacted very poorly, if at all. 
For production of monoclonal antibodies, 
BALB/c mice were immunized intraperitoneally 
by 4 weekly injections of 50 pg Fn purified to the 
penultimate step [lo] mixed with an equal volume 
of Freund’s adjuvant. 
0 
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Two mice with the highest antibody titer to 
highly purified Fn, as determined by ELISA, were 
selected for hybridoma production and received 
another injection. Fusion experiments were per- 
formed 3 days after the last injection. Spleen cells 
were fused with NS-1 myeloma cells as in [15]. 
Briefly, spleen and myeloma cells mixed in a ratio 
of 4: 1 were fused in the presence of 50% (v/v) 
polyethylene glycol 1600. The fused cells were 
dispersed in hypoxanthine/aminopterin/thymidine 
medium in microtiter wells and maintained until 
macroscopic colonies were formed. Supernatants 
I r’, ‘\\ MAbE ‘. \O ‘. Al 
400 60 16 3.2 0.64 0.13 0.026 
nliters oscitic fluid 
Fig.1. Immunoreactivity of MAb I and IV with FB. 
ELISA plates were coated with 200 ng purified Fa per 
well in 2004 of 0.05 M Na-carbonate buffer and 
further reactions were carried out with serially diluted 
ascitic fluids as in [13]. The amount of ascitic fluid 
(MAb I or IV) indicated in the figure was taken in 200 pl 
PBS-Tween buffer. 
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MAb I and IV have been identified by ELISA to 
be mouse immunoglobulin subtype IgGi. Both 
monoclonals were found to contain the x light 
chain. 
3.1. Reaction of monoclonal antibodies with 
different forms of isolated FB 
Fa has been shown to have a reactive dithiol that 
is required for its activity [16]. Fa appears to 
undergo gross conformational changes when 
treated with -SH alkylating agents, such as N- 
ethylmaleimide or -SH oxidising agents such as 
copper-o-phenanthroline, that are reflected in 
altered mobilities on SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) [7]. 
Reduced, alkylated and oxidized forms of Fa 
moved with a mobility corresponding to M, values 
of 17700, 22000 and 16400, respectively, on 
SDS-PAGE, but these changes did not affect the 
reactive epitope on the protein or its accessibility to 
MAb I [7]. MAb I reacted also with some of the 
peptides of Fa formed on partial digestion with 
trypsin (fig.2), indicating that MAb I is a highly 
sensitive and specific probe to follow Fa. It is in- 
teresting to note that trypsin activity was not com- 
pletely inhibited by soyabean trypsin inhibitor in 
the presence of SDS (see fig.%, lane 7). 
Spot tests for antigen-antibody reactivity were 
carried out by incubating 36 mU partially purified 
Fa in 35 ~1 of different denaturants for 5 h at room 
temperature and spotted directly on the 
nitrocellulose paper. Immunostaining was carried 
out with either MAb I or IV as described in section 
2. When the spot test was carried out with different 
samples of denatured Fa, MAb I showed con- 
siderably reduced reactivity towards Fa treated 
with 1.0% SDS, 1.0% P-mercaptoethanol, but 
MAb IV appears to react nearly as well. Treatment 
of Fn with 7.0 M urea, 1.0% fi-mercaptoethanol 
did not affect the reaction with either MAb. MAb 
I reacted poorly with Fa treated with 5.0 M 
guanidine HCl, 1 .O% ,&mercaptoethanol whereas 
the reaction with MAb IV was not affected (not 
shown). 
3.2. Reactivity of monoclonal antibodies with 
membrane preparations 
As small an amount as 50 ng Fa could be 
detected on immunoblots when both MAb I and 
IV, diluted to 1: 2000 in PBS-Tween were used 
1 2 3 4 5 6 7 
Fig.2. Immunoreactivity of MAb I with tryptic peptides 
from Fa. Partially purified FB (0.2 units factorB in 50 ~1) 
was incubated with 0, 2, 4, 12, 24 and 50 pg trypsin for 
15 min at 30°C and the reaction was stopped by the 
addition of a 5-fold excess of soybean trypsin inhibitor 
in 1-12~1 (nos l-6). To one sample of FB, 25Opg 
inhibitor was added before the addition of 50 pg trypsin 
(no.7). The reaction mixture (40~1) was dispersed in 
40~1 digestion mixture (0.18 M Tris-Cl, pH 6.8, 2.8% 
SDS, 7% fl-mercaptoethanol, 28% glycerol), and 20-,J 
aliquots from each were loaded on the gel and 
electrophoresis and immunoblotting were carried out as 
in [14]. FB digestion in sample 7 indicates that the 
inhibitor does not inactivate trypsin in the presence of 
SDS. 
together, reaching a sensitivity somewhat greater 
than the silver staining method. When 8Opg 
mitochondria, ETPu, FB-deficient AE-particles, 
H+-ATPase, and Fn were immunoblotted in a 
similar way, one specific immunoreactive band 
corresponding to isolated Fa was evident in all 
these preparations (fig.3). However, the intensity 
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Fig.3. Reactivity of membrane bound Fa to MAb I in 
immunoblots. Mitochondria (l), ETPn (2), AE-particles 
(3), H+-ATPase (8 mg/ml) (4) and Fa (1.3 a/ml) (5) 
were mixed with an equal volume of digestion mixture 
(see fig.2). Aliquots of 20~1 from each sample 
containing 8Opg membrane protein in l-4 and 13 mU 
Fa in 5 were loaded on the gel. Electrophoresis and 
immunoblotting were carried out as in (141. Ascitic 
fluids of MAb I and IV were diluted 1: lOOO-fold, mixed 
in equal volumes and used for immunostaining. 
of the reactive band in the H+-ATPase preparation 
was not as high as expected although the sample 
contained approx. 2 pg FB [ 131, an amount well in 
excess of the binding capacity of the nitrocellulose 
paper. Treatment of these preparations with 
50 mM N-ethylmaleimide, 1 mM copper o- 
phenanthroline, 6 M urea, trypsin, phospholipase 
AZ, phospholipase C, or lipase did not improve the 
intensity of the immunoreactive band. It is con- 
ceivable that in membrane preparations, the 
epitope recognized by these monoclonal antibodies 
is mostly shielded. 
3.3. Effect of MAb on Fs-stimulated ATP driven 
NAD+ reduction by succinate, i.e., reversed 
electron flow activity 
The standard assay for Fn involves measurement 
of the stimulation of reversed electron flow activity 
of AE-particles [lo]. Treatment of Fn with MAb I 
or IV prior to its addition to AE-particle abolished 
its ability to stimulate the AE-particle. When lo-p1 
aliquots (15-35 mU Fa activity) of partially 
purified Fn (n = 5) were incubated with 2 ~1 of 
either MAb I or MAb IV ascitic fluid for 2 min at 
room temperature before addition of AE-particles, 
70-80% loss in Fn activity was observed. The reac- 
tion was specific since the same amount of ascitic 
fluid, which showed no reaction to Fg in im- 
munoblots, did not have any effect on Fn activity. 
Inhibition caused by MAb I and IV was concen- 
tration and time dependent (table 1). The extent of 
inhibition was affected only a little if the antibody 
Table 1 
Inhibition of Fa-stimulated ATP-driven NAD+ 
reduction activity of AE-particles by MAb 
Ascitic fluid pmol NADH - min- ’ + ml-’ 
W) 
Control 2 min 1 h 3 h 1 h” 
MAb I 
1 2.4 1.9 1.2 0.7 1.3 
5 2.4 1.2 0.5 0.1 0.7 
MAB IV 
1 2.4 1.9 1.2 1.1 1.9 
5 2.4 1.6 0.7 0.5 0.8 
a lop1 of Fn (2.4 U/ml) was first added to the AE- 
particles (0.5 mg contained in 25 ~1) and incubated for 
1 min at 38°C. To this mixture 10~1 of appropriately 
diluted ascitic fluid was added, keeping the effective 
concentration same as in the experimental samples, 
incubated for 1 h in ice and assayed as usual 
Fn (75 pl of 2.4 U/ml) was incubated in ice with 1 or 5 /tl 
ascitic fluid and lo-~1 aliquots were assayed after 2 min, 
1 h and 3 h incubation as described in section 2. The Fn 
assays were by its stimulation of AE-particle activity in 
catalyzing ATP-dependent NAD+ reduction by 
succinate 
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was added to Fn before or after the addition of 
AE-particles (table 2). The same levels of ascitic 
fluid did not show any effect on the particle activi- 
ty. Results indicated that loss of factor B activity 
was accompanied by failure of binding of Fn to 
AE-particle (not shown). Whether the antibody in- 
terferes in the binding of Fn to AE-particle or pro- 
motes dissociation of reconstituted Fn molecule 
from AE-particles is not yet clear. Whether the 
antibodies change the conformation of FB to cause 
inactivation is being further investigated. 
MAb I and IV did not have any effect on the ac- 
tivity of ETPu in the ATP-dependent reduction of 
NAD+ by succinate. This is anticipated from 
previous similar data with rabbit antiserum to Fn 
[17] and indicates that the Fn molecule is well 
shielded in the H+-ATPase complex. 
MAb I failed to react with Fn denatured with 
guanidine HCI in the spot reaction on 
nitrocellulose paper, whereas MAb IV reactivity 
was unaffected. It is possible that these two Abs 
are directed against different sites on Fn or MAb 
I reaction is affected by the tertiary structure of Fn 
to a greater extent than the MAb IV reaction. 
Fn has proved to be a poor immunogen and 
several attempts in our laboratory to make potent 
rabbit antiserum have failed. The MAb I and IV 
have a high titer. This property and the specificity 
of MAbs in general to one particular epitope make 
them valuable for studying both the functional and 
structural aspects of Fn. Preparation of MAbs to 
Fn has been reported for the first time here. 
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